New drug aims to reverse Cancer-Related wasting
Symptom relief
Not yet recruiting
This study tests a new drug called ASCA101 for cachexia, a condition where people with cancer lose weight and muscle. About 135 adults with certain solid tumors will receive ASCA101, an active control, or a placebo for 12 weeks. The main goal is to see if the drug helps increase …
Phase: PHASE2 • Sponsor: MetaFines • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC